Mivacron (AbbVie Inc.)


Welcome to the PulseAid listing for the Mivacron drug offered from AbbVie Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: AbbVie Inc.
NON-PROPRIETARY NAME: Mivacurium Chloride
SUBSTANCE NAME: MIVACURIUM CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-01-30
END MARKETING DATE: 0000-00-00


Mivacron HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMivacron from AbbVie Inc.
LABELER NAME: AbbVie Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 2015-01-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0074-4365_1a74ec2a-f5a4-3296-d411-1c10ab3ae676
PRODUCT NDC: 0074-4365
APPLICATION NUMBER: NDA020098

Other MIVACURIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Mivacron